- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
PMCPA Director complaint about clinical trial disclosure for Zelboraf. The matter was found outwith the scope of the ABPI Code (2015). No…
Anonymous complaint about a meeting advertised on LinkedIn involving Boehringer Ingelheim. PMCPA concluded no breach and that the matter was outwith the…
A pharmacist alleged Servier reused a Coversyl ad previously ruled misleading. The Panel found the ad had been revised to clarify combination…
A public complaint about a newspaper article quoting ProStrakan on Rectogesic’s indication and comparisons with surgery. Panel focused on what the company…
Recordati’s Tradorec XL leavepiece quoted ‘MHRA advice’ on prescribing prolonged-release tramadol by brand. The Panel ruled this breached Clause 9.5: MHRA references…
A PCT public health consultant alleged Pfizer’s Champix promotion was premature (pre-NICE), undermined local guidelines/NRT, and bypassed the stop smoking service. The…
GW’s HCP website pages were ruled promotional for Sativex but lacked required prescribing information, and its pipeline section was found to promote…
A medical representative alleged AstraZeneca meetings were visible to the public and that surgery meetings were fund-raising with no education. The PMCPA…
A PCT pharmacist challenged a GSK-sponsored RLS awareness poster in GP practices as misleading and indirect POM advertising. The PMCPA Panel found…
Complaint about GSK’s sponsorship of drug testing in sport. PMCPA found the matter outwith the scope of the ABPI Code; no breach.…
Anonymous complaint about alleged promotion of Levitra by Bayer. PMCPA recorded the matter as outwith the scope of the Code; no case…
GSK was found in breach for misleading “efficacy in 3 steps: Open Inhale Close” claims in Relvar digital sales aids and for…
Ferring agreed in inter-company dialogue to withdraw a Cortiment leavepiece but it was still used at a conference weeks later. Panel found…
PMCPA ruled Vifor breached undertakings by using materials and a medical information email that misleadingly compared Ferinject vs Monofer on hypersensitivity/ADRs, and…
Eliquis promotional email used July 2019 prescribing information after an Oct 2019 SPC update on reversal agent/overdose. Panel found PI content sufficient…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.